Skip to content

Haemonetics HAE Ratios & Valuation

TTM Q4 '26TTM Q3 '26TTM Q2 '26TTM Q1 '26TTM Q4 '25
Profitability
Gross margin59%-0.3pp59.4%+1.1pp58.3%+1.3pp56.9%+1.9pp55%+1.8pp
Efficiency
Asset turnover0.6×0.0×0.5×0.0×0.5×0.0×0.5×0.0×0.6×0.0×
Liquidity
Current ratio+1.2×1.7×+0.1×1.6×-0.1×1.7×+0.1×1.6×-2.4×
Leverage
Debt-to-equity1.6×+0.3×1.3×-0.1×1.4×+0.1×1.4×-0.2×1.6×+0.2×
Per Share
Book value per share$16.82-13.3%$19.40+8.9%$17.82-2.4%$18.25+12.8%$16.18-9.6%
Valuation
Market capitalization$2.62B-30.2%$3.75B+59.8%$2.35B-33.1%$3.51B+9.9%$3.19B-18.6%
Price / sales-0.9×2.8×+1.1×1.8×-0.8×2.6×+0.3×2.3×-0.5×
Price / book3.3×-0.8×4.1×+1.4×2.8×-1.2×+0.1×3.9×-0.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Haemonetics's profit margins?
Haemonetics (HAE) runs a 59.0% gross margin and a 19.0% operating margin, with a 13.3% net margin.
Where do Haemonetics's ratios come from?
Every ratio is computed from Haemonetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.